Used in neuroscience and biomedical research to quantitatively measure dopamine levels in rat biological samples such as serum, plasma, cerebrospinal fluid, or tissue homogenates. Enables researchers to study dopamine-related pathways and neurotransmission in models of neurological disorders including Parkinson’s disease, schizophrenia, addiction, and depression. Supports evaluation of drug effects, behavioral studies, and neurochemical changes in experimental animals. Provides a sensitive and specific method for high-throughput screening in preclinical studies.